DonaldC.ManningMDPhD

Anesthesiology • Parsippany, NJ

Pain Medicine, Regional Anesthesiology, Clinical Pharmacology

Chief Medical Officer

Join to view full profile

Dr. Manning is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Manning's full profile

Already have an account?

Office
Pacira Biosciences
5 Sylvan Way
Parsippany, NJ 07054
Phone+1 973-451-4019

Education & Training

Johns Hopkins UniversityFellowship, Pain Medicine, 1991 - 1992
Johns Hopkins UniversityResidency, Anesthesiology, 1989 - 1991
MedStar Health (Baltimore)Residency, Internal Medicine, 1988 - 1989
Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 1986 - 1988
Johns Hopkins University School of MedicineClass of 1988

Certifications & Licensure

VA State Medical License 1993 - 2026
American Board of Anesthesiology Anesthesiology

Clinical Trials

A Study of CC-5013 in the Treatment of Complex Regional Pain Syndrome (CRPS) Start of enrollment: 2003 Aug 01
Completed
Phase 2
Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1 Start of enrollment: 2005 Feb 01
Terminated
Phase 2
Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery Start of enrollment: 2014 May 01
Completed
Phase 2

Publications & Presentations

PubMed

2 citations
A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase.
Donald C. Manning, Joseph Gimbel, Robert E Wertz Md, Richard Rauck, Alyse Cooper
Pain Medicine. 2016-08-22
20 citations
Lenalidomide for Complex Regional Pain Syndrome Type 1: Lack of Efficacy in a Phase II Randomized Study
Donald C. Manning, Guillermo M. Alexander, Joseph C. Arezzo, Alyse Cooper, R. Norman Harden
The Journal of Pain. 2014-12-01
29 citations
Single intrathecal administration of the transcription factor decoy AYX1 prevents acute and chronic pain after incisional, inflammatory, or neuropathic injury
Julien Mamet, Michael Klukinov, Tony L. Yaksh, Shelle Malkmus, Samantha Williams
Pain. 2014-02-01

Press Mentions

Ex-AstraZeneca Exec Kristen Buck Hops Aboard Icon as CMO; Immunocore Taps Brian DiDonato as CFOMay 8th, 2020
Adynxx a Biopharmaceutical Company, Develops Pain Management DrugsJuly 17th, 2019